ORIGINAL ARTICLES

Construction and identification of macrophage migration inhibitory factor gene knockout strain of Toxoplasma gondii

  • WANG Jie ,
  • WEN Hong-yang ,
  • CHEN Ying ,
  • AN Ran ,
  • LUO Qing-li ,
  • SHEN Ji-long ,
  • DU Jian
Expand
  • 1. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China
    2. The Provincial Key Laboratory of Zoonoses of High Institutions in Anhui, Hefei 230032, China
    3. Research Center for Infectious Diseases, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China
    4. The Key Laboratory of Microbiology and Parasitology of Anhui Province, Hefei 230032, China

Received date: 2021-10-15

  Revised date: 2021-12-01

  Online published: 2022-07-06

Supported by

National Natural Science Foundation of China(82072300);National Natural Science Foundation of China(81871674);National Natural Science Foundation of China(81902084)

Abstract

Objective To construct and validate a macrophage migration inhibitory factor (mif) gene knockout strain of Toxoplasma gondii RH strain. Methods Single guide RNA (sgRNA) and site-directed mutation primers the RH strain of T. gondii Tgmif gene were designed. The pSAG1::Cas9-U6::sgUPRT plasmid was mutated into the pSAG1::Cas9-U6::sgTgmif plasmid targeting the Tgmif gene. A Tgmif donor plasmid containing 3 fragments of 1 001 bp upstream of Tgmif (Tgmif-up), dihydrofolate reductase-thymidylate synthase gene (dhfr-ts) and 1 011 bp downstream of Tgmif (Tgmif-down) was constructed. The Tgmif donor DNA was amplified from the Tgmif donor plasmid by PCR. The pSAG1::Cas9-U6::sgTgmif plasmid and Tgmif donor DNA were mixed and electroporated into the tachyzoites of wild-type T. gondii RH strain (RHWT) and cultured with pyrimethamine for 7 days prior to screening to obtain the stable expression of pyrimethamine-resistant tachyzoites. The upper and lower homology arms of dhfr-ts and Tgmif were amplified by PCR to identify Tgmif knockout monoclonal strains (RHΔTgmif). The protein of RHΔTgmif and RHWT tachyzoites was extracted and the expression of TgMIF protein was analyzed by Western blotting. RHΔTgmif was cultured in human foreskin fibroblasts (HFF) cells for 10 passages, and the number of tachyzoites per 100 HFF cells was counted by Giemsa staining to evaluate the proliferation of RHΔTgmif in HFF cells in vitro. RHWT was used as the control. Twenty BABL/c mice were randomly divided into RHWT group and RHΔTgmif group (10 mice/group). The mice were injected intraperitoneally with tachyzoites of RHWT or RHΔTgmif strains (1 000/mouse) for each group respectively. The survival of mice was recorded. Independent sample t-test was used to compare the proliferation of T. gondii, and Log Rank test was used to compare the survival rate of mice. Results PCR results showed that the Tgmif donor DNA fragment containing 3 fragments, including Tgmif-up, dhfr-ts and Tgmif-down was 5 049 bp long, which was as expected; RHΔTgmif strain amplified dhfr-ts upstream and downstream homology arm bands of 1 387 bp and 1 524 bp, respectively, while RHWT strain had no corresponding bands; a 1 837 bp Tgmif band was amplified in RHWT strain, while no corresponding band in RHΔTgmif strain. The results of Western blotting showed that the RHWT strain had a protein band at a relative molecular mass (Mr) of 12 500, while the RHΔTgmif strain had no corresponding protein band. The results of Giemsa staining showed that the tachyzoites of RHΔTgmif strain were (2 986 ± 69.20) per 100 HFF cells, which was higher than the RHWT strain (2 067 ± 51.08) (t = 18.50, P < 0.01). The results of the in vivo virulence test showed that the mice in the RHWT group started to die on the 7th day and all died on the 9th day; the mice in the RHΔTgmif group started to die on the 5th day and all died on the 7th day, and the difference between the two groups was statistically significant (χ2 = 17.45, P < 0.01). Conclusion The Tgmif gene knockout strain RHΔTgmif was successfully constructed, and the RHΔTgmif strain of Toxoplasma was more virulent than the RHWT strain.

Cite this article

WANG Jie , WEN Hong-yang , CHEN Ying , AN Ran , LUO Qing-li , SHEN Ji-long , DU Jian . Construction and identification of macrophage migration inhibitory factor gene knockout strain of Toxoplasma gondii[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022 , 40(3) : 349 -354 . DOI: 10.12140/j.issn.1000-7423.2022.03.011

References

[1] Pan M,, Lyu C, ZhaoJ, et al. Sixty years (1957—2017) of research on toxoplasmosis in China: an overview[J]. Front Microbiol, 2017, 8: 1825.
[2] Shen JL,, Wang L. Genotypes and main effectors of Toxoplasma gondii and their pathogenic mechanisms[J]. Chin J Parasitol Parasit Dis, 2015, 33(6): 429-435. (in Chinese)
[2] ( 沈继龙,, 王林. 弓形虫的基因型及其主要效应分子的致病机制[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 429-435.)
[3] Montoya JG,, Liesenfeld O. Toxoplasmosis[J]. Lancet, 2004, 363(9425): 1965-1976.
[4] Zeng JL,, Na RH,, Chen AY, et al. Observation of the feline intestinal epithelial cell infected with Toxoplasma gondii[J]. Chin J Parasitol Parasit Dis, 2015, 33(1): 32-34. (in Chinese)
[4] ( 曾俊岭,, 娜仁花,, 陈艾媛, 等. 刚地弓形虫感染猫肠上皮细胞的初步观察[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(1): 32-34.)
[5] Xu XQ,, Liao DJ,, Feng X, et al. Status of Toxoplasma infection in pregnant and postpartum women in Duyun District of Guizhou Province during 2015—2018[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 165-167. (in Chinese)
[5] ( 徐晓青,, 廖德君,, 冯霞, 等. 2015—2018年贵州省都匀地区孕产妇弓形虫感染情况调查[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 165-167.)
[6] Opsteegh M,, Kortbeek TM,, Havelaar AH, et al. Intervention strategies to reduce human Toxoplasma gondii disease burden[J]. Clin Infect Dis, 2015, 60(1): 101-107.
[7] Osipyan A,, Chen D,, Dekker FJ. Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation[J]. Drug Discov Today, 2021, 26(7): 1728-1734.
[8] Bernhagen J,, Krohn R,, Lue HQ, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment[J]. Nat Med, 2007, 13(5): 587-596.
[9] Kang I,, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine[J]. Nat Rev Rheumatol, 2019, 15(7): 427-437.
[10] Sommerville C,, Richardson JM,, Williams RAM, et al. Biochemical and immunological characterization of Toxoplasma gondii macroph-age migration inhibitory factor[J]. J Biol Chem, 2013, 288(18): 12733-12741.
[11] Rosado J,, Rodriguez-Sosa M. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections[J]. Int J Biol Sci, 2011, 7(9): 1239-1256.
[12] Holowka T,, Castilho TM,, Garcia AB, et al. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence[J]. FASEB J, 2016, 30(6): 2249-2265.
[13] Shen B,, Brown KM,, Lee TD, et al. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9[J]. mBio, 2014, 5(3): e01114-e01114.
[14] Fu YX,, Kong QM,, Lu SH. Research development of CRISPR/Cas9 system on parasitic studies[J]. Chin J Parasitol Parasit Dis, 2017, 35(3): 299-304. (in Chinese)
[14] ( 付益修,, 孔庆明,, 陆绍红. CRISPR/Cas9系统在寄生虫领域的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(3): 299-304.)
[15] Leng L,, Metz CN,, Fang Y, et al. MIF signal transduction initiated by binding to CD74[J]. J Exp Med, 2003, 197(11): 1467-1476.
[16] Marcon CF,, Ferreira PTM,, Franco PS, et al. Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection[J]. Cytokine, 2020, 136: 155283.
[17] Kwon HJ,, Won YS,, Suh HW, et al. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis[J]. J Immunol, 2010, 185(7): 3980-3989.
[18] Ghosh S,, Jiang N,, Farr L, et al. Parasite-produced MIF cytokine: role in immune evasion, invasion, and pathogenesis[J]. Front Immunol, 2019, 10: 1995.
[19] Kamir D,, Zierow S,, Leng L, et al. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses[J]. J Immunol, 2008, 180(12): 8250-8261.
[20] Liang L,, Liu HP,, Cao JP. Functional roles of macrophage migration inhibitory factor in anti-parasitic diseases[J]. Chin J Parasitol Parasit Dis, 2012, 30(1): 56-60. (in Chinese)
[20] ( 梁乐,, 刘海鹏,, 曹建平. 巨噬细胞迁移抑制因子的抗寄生虫病作用研究[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(1): 56-60.)
[21] Liu K,, Wen HY,, Cai HJ, et al. Protective effect against toxoplasmosis in BALB/c mice vaccinated with Toxoplasma gondii macrophage migration inhibitory factor[J]. Front Microbiol, 2019, 10: 813.
Outlines

/

〈 〉